4
Changes in Ownership
Atara Biotherapeutics, Inc. Filed Acc 0001209191-19-011187
EVP, R&D & Chief Scientific Of sold 775 shares at $39.59 ($30,682)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Haqq Christopher EVP, R&D & Chief Scientific Of | 2019-02-15 | Sale | −775 | $39.59 | $30,682 | 271,943 | D |
| Open-market sales · 775 sh · avg $39.59 · $30,682 | |||||||
Loading xslF345X03/doc4.xml…